Trial Profile
A Randomized, Placebo-controlled, Double-blind Phase I Study to Explore Safety, Tolerability and Pharmacodynamics of CyPep-1 in Subjects With Cutaneous Warts
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs CyPep-1 (Primary)
- Indications Warts
- Focus Adverse reactions; First in man
- 02 Aug 2021 Status changed from recruiting to completed.
- 04 Mar 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Mar 2019}.
- 27 May 2020 According to a Cytovation media release, the company expects to read out the results from this ongoing study in the coming months.